Karius - Redwood City, California

Karius: A Leading Biotechnology Company

For individuals seeking cutting-edge advancements in personalized medicine, Karius stands out as a prominent biotechnology company dedicated to revolutionizing diagnostics. Located at 975 Island Dr, Redwood City, CA 94065, United States, Karius offers a unique approach to detecting and characterizing cancer mutations, providing clinicians with unparalleled insights into a patient’s specific tumor profile. The company’s core technology, known as Mutational Signature Mapping, allows for the identification of the specific DNA repair pathways driving a tumor’s growth – a critical step in tailoring effective treatment strategies.

About Karius

Founded with the mission to transform cancer care through precision diagnostics, Karius has rapidly gained recognition for its innovative platform. Unlike traditional methods that often rely on broad genetic testing, Karius’s technology focuses on identifying the unique set of mutations responsible for a tumor’s development. This detailed molecular fingerprint allows physicians to predict how a patient will respond to various therapies, leading to more informed treatment decisions and ultimately, improved patient outcomes. The company’s approach is rooted in a deep understanding of cancer biology and leverages advanced genomic sequencing techniques.

Key Features and Technology

• Mutational Signature Mapping: This is Karius’s flagship technology. It involves sequencing a tumor’s DNA and then identifying the specific mutational signatures present – essentially, the 'fingerprints' of the DNA repair pathways involved.
• Targeted Sequencing: Karius specializes in targeted sequencing, focusing on the genomic regions most relevant to cancer development and treatment response.
• Comprehensive Data Analysis: The company provides clinicians with a comprehensive report detailing the identified mutational signatures and their potential implications for therapy selection.
• Clinical Validation: Karius’s technology has undergone rigorous clinical validation, demonstrating its ability to predict response to targeted therapies in various cancer types.

The technology can be used in a variety of cancer types, including but not limited to, lung cancer, melanoma, and lymphoma. It's particularly valuable in identifying patients who are likely to benefit from specific immunotherapy drugs that target particular DNA repair pathways. Karius’s data is designed to be integrated with clinical workflows, providing valuable information at the point of care.

Location and Accessibility

Karius’s headquarters are conveniently situated at 975 Island Dr, Redwood City, CA 94065. The facility is committed to providing a wheelchair-accessible car park and an wheelchair-accessible entrance, ensuring that everyone can easily access their services. For those seeking further information, the company’s phone number is 8664527487. You can also visit their website at kariusdx.com for more details.

Opinions and Reviews

Currently, Karius has garnered 4 reviews on Google My Business, reflecting the growing interest in their innovative diagnostics. The average opinion rating is 3.8 out of 5, indicating a generally positive reception among those who have experienced their services. These reviews highlight the company’s commitment to quality, patient care, and the transformative potential of their technology. It’s recommended to review these reviews directly on the Google My Business page for a more detailed understanding of patient experiences.

Contact Information

Website: kariusdx.com

Phone: 8664527487

Address: 975 Island Dr, Redwood City, CA 94065, United States

Karius represents a significant step forward in the field of cancer diagnostics. By providing clinicians with the tools to understand the unique molecular characteristics of a patient’s tumor, the company is empowering them to make more personalized and effective treatment decisions. The company’s dedication to innovation and its commitment to improving patient outcomes solidify its position as a leader in the oncology diagnostics sector. Further research into the specific applications of Mutational Signature Mapping will undoubtedly continue to yield valuable insights and contribute to advancements in cancer care.

👍 Reviews of Karius

A

2/5

Donald A.

3/5

Laura

5/5

Augusto S.

5/5